Business Wire

Wellness Market Leaders Join Forces: The DRIPBaR Powered by REVIV

Share

The DRIPBaR, recognized as the fastest-growing IV therapy franchise in the United States, has joined forces with REVIV, the global leader in IV therapy, marking a significant milestone for the industry. The partnership creates an unrivaled offering by bringing together the specialties of two industry heavyweights boasting over 200 locations across 6 continents, with plans to add thousands more locations in the coming years. The recent surge in demand for IV therapy presents enormous opportunities globally for the companies to redefine industry standards and spearhead the next era of IV therapy.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240301173923/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Ben Crosbie, CEO of The DRIPBaR and Sarah Lomas, Founder and CEO of REVIV Global, announce their exciting partnership. (Photo: Business Wire)

With an extensive pipeline boasting over 450 franchisees in the United States, The DRIPBaR's decision to integrate REVIV's proprietary technology-backed proposition, REVIV X, validates their commitment to provide personalized and precision nutrition solutions for their customers. This partnership empowers The DRIPBaR to leverage REVIV's 10 years of intellectual property and life science expertise, utilizing objective data from blood tests and DNA analysis to tailor IV therapies to individual needs. Through REVIV X, The DRIPBaR is poised to revolutionize the wellness landscape in the United States, offering patient-focused solutions that optimize health outcomes that will solidify its position as a leader in innovation.

Ben Crosbie, CEO of The DRIPBaR, expressed excitement in the collaboration, affirming, "By selecting REVIV as our strategic partner, we are unlocking personalized and precision capabilities for a more advanced product offering and customer experience. I’m very confident that leveraging REVIV's cutting-edge technology and expertise will accelerate the growth of our franchisees and position them ahead of industry norms. The REVIV X proposition, coupled with its accredited IV Academy training course, sets a global benchmark for excellence in our field, empowering us to maintain industry leadership."

Sarah Lomas, Founder and CEO of REVIV Global, highlighted the transformative impact of the partnership, stating, "The DRIPBaR's alignment with REVIV underscores our joint dedication to innovation and safety in the IV therapy market. As industry leaders, we are reshaping the future of wellness by offering personalized and precision nutrition solutions that cater to evolving customer needs. We will continue to develop our SaaS products to power the industry globally. After many years and significant investment in research and product development, it’s exciting to see such early validation and adoption for REVIV X."

This strategic alliance between REVIV and The DRIPBaR marks a pivotal moment in the IV therapy industry and multi-modality sectors, advancing the delivery of safe, effective, and tailored wellness solutions to customers across the United States and beyond. As the IV therapy market continues its rapid expansion, with safety and compliance at the forefront, REVIV X emerges as the solution of choice for IV therapy operators, creating the opportunity for existing multi-modality businesses to access REVIV's innovative solutions and maintain their position at the forefront of wellness innovation and industry standards.

About REVIV Global

REVIV Global is at the forefront of advanced wellness solutions, devoted to enriching health and vitality through state-of-the-art IV therapy treatments. With a widespread international footprint and a relentless pursuit of innovation, REVIV is spearheading a revolution in the wellness sector. Its distinctive technological platform empowers IV therapy providers to deliver personalized and precision solutions with unparalleled safety and efficiency.

About The DRIPBaR

The DRIPBaR, a pioneering brand in the realm of wellness, is poised to redefine the landscape of health and vitality through advances in IV therapy. With cutting-edge science and a strong commitment to safety, The DRIPBaR offers a transformative approach to cellular health and personalized care. Focusing on ever-evolving treatments and medical advancements, The DRIPBaR embraces a new era of wellness where rejuvenation, vitality, and optimized health converge.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For media inquiries:
REVIV Global: Emma Robertson, erobertson@revivme.com
The DRIPBaR: Marketing@thedripbar.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Novotech Supports Groundbreaking Approval of Anlotinib Combination Therapy for Advanced Soft Tissue Sarcoma28.8.2025 23:15:00 EEST | Press release

Novotech, a globally recognized full-service clinical research organization (CRO), is proud to have partnered with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ Pharma) in achieving a significant regulatory milestone: the approval of Anlotinib Hydrochloride Capsules for a new indication as a first-line treatment for unresectable locally advanced or metastatic soft tissue sarcoma (STS) in combination with chemotherapy. This approval marks the ninth indication for Anlotinib in China and represents the world’s first official approval of an Anlotinib-chemotherapy combination for first-line treatment of advanced or metastatic STS. Previously recommended as a second-line monotherapy by the Chinese Society of Clinical Oncology (CSCO) guidelines, Anlotinib was the only Grade I targeted therapy for STS. This new indication represents a significant advancement for patients who have not previously received systemic treatment, expanding access to more effective and targeted first-line the

BEYOND Developments Reveals the Middle East’s First Forest District by the Sea, Featuring Talea as its First Residential Tower28.8.2025 23:03:00 EEST | Press release

As part of its ongoing commitment to shaping future-focused communities, BEYOND Developments has announced the launch of the Middle East’s first Forest District by the Sea, and Talea, the first in a series of residential towers that will bring this vision to life. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250828822584/en/ Talea by Beyond, a rare fusion of ocean, forest, and skyline views, where nature and design live in perfect harmony (Photo: AETOSWire) Set in Dubai Maritime City, this pioneering destination is a coastal haven centered on nature, wellness, and sustainability. By championing this nature-first approach, BEYOND Developments supports Dubai’s transformation into a global leader in sustainable, resilient urban living, aligned with the Dubai 2040 Master Plan, Net Zero 2050, and D33 Agenda. According to Adil Taqi, CEO of BEYOND Developments, this launch marks more than the beginning of a new residential offeri

Lattice to Showcase Industrial IoT and Security Innovation Leadership at FPGAworld Conference 202528.8.2025 23:00:00 EEST | Press release

Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced its participation in the upcoming FPGAworld Conference 2025, taking place on Sept. 9, 2025 in Sweden. As part of the conference’s technical program, Lattice will deliver presentations and host a demo showcase focused on advanced Industrial IoT and secure system design based on Lattice FPGAs. Who: Lattice Semiconductor What / When (GMT+2): Sept. 9, 2025 Demo showcase Presentations (Track: 12:50 – 2:05 p.m.): Industrial IoT Challenges and Solution for Real Time Communication Building High Security Systems with Lattice FPGAs Where: FPGAworld Conference, AFRY, Frösundaleden 2A, 169 70 Solna, Sweden The FPGAworld Conference is an international forum for researchers, engineers, teachers, students, and hackers. It covers topics such as complex analog/digital/software FPGA SoC systems, FPGA/ASIC-based products, educational & industrial cases, and more. Supporting Resources For more information about Lattic

KEO World Inc. announces Business Combination of its Global Trade Card (GTC) program with MAHA Capital28.8.2025 22:43:00 EEST | Press release

KEO World Inc., a lending fintech infrastructure platform for embedded credit B2B payments, today officially entered into a binding agreement to combine its GTC business with MAHA Capital AB, a publicly listed investment company on Nasdaq Stockholm. This transaction is designed to significantly strengthen our financial foundation and accelerate our global expansion. MAHA brings over USD 120 million in cash and liquid assets, while Keo investors will contribute an additional USD 35 million. Together, the combined company will have approximately USD 155 million of equity to deploy into the GTC program. As part of its growth strategy, the combined entity also intends to pursue a dual listing on Nasdaq in the United States, broadening investor access, enhancing liquidity, and positioning our company on the global stage. Under the agreement, Keo will transfer its GTC operations, including its SPV and Keo Puerto Rico LLC, which holds our Amex issuing license, to MAHA. Once completed, and sub

Biedermann Medtech Group Announces Transformation of U.S. Spine Market Approach and New Business Model28.8.2025 19:00:00 EEST | Press release

The Biedermann Medtech Group, the prominent innovator in next generation spinal and extremity implant systems and procedural solutions, today announced a strategic transformation of its U.S. operations. Biedermann will expand its focus beyond product distribution to a broader platform of integrated services and solutions designed to reshape its U.S. business model. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250828746562/en/ As part of this transition, Biedermann Motech will discontinue to directly distribute its product lines of advanced solutions for spinal and extremity surgery in the U.S. market in the near future. This decision follows a comprehensive and detailed review of market dynamics and recent macro-economic developments. In the next phase of this transformation, Biedermann Motech will leverage its strategic partnership with intellectual property powerhouse and recognized innovation leader Biedermann Technolog

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye